PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM ExpressionKim H.T. Paraiso, Keiran S.M. Smalley|Cancer Research|2011Cited by 546
Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapyKim H.T. Paraiso, Keiran S.M. Smalley|British Journal of Cancer|2010Cited by 313